Chronic Obstructive Pulmonary Disease

  • Incruse 2018 report

    Incruse 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Lonhala Magnair 2018 report

    Lonhala Magnair 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 27 Pages The 5 Key Questions Addressed by this...

  • Perforomist 2018 report

    Perforomist 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Seebri Neohaler 2018 report

    Seebri Neohaler 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 27 Pages The 5 Key Questions Addressed by this...

  • Spiriva 2018 report

    Spiriva 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Stiolto 2018 report

    Stiolto 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 21 Pages The 5 Key Questions Addressed by this Report:...

  • Symbicort 2018 report

    Symbicort 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Trelegy Ellipta 2018 report

    Trelegy Ellipta 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this...

  • Tudorza 2018 report

    Tudorza 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 26 Pages The 5 Key Questions Addressed by this Report:...

  • Utibron 2018 report

    Utibron 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 25 Pages The 5 Key Questions Addressed by this Report:...

  • Yupelri 2018 report

    Yupelri 2018 U.S. PROMOTIONAL AUDIT REPORT Published July 2019 • 24 Pages The 5 Key Questions Addressed by this Report:...

  • Advair 2017 report

    Advair 2017 U.S. PROMOTIONAL AUDIT REPORT Published July 2018 • 19 Pages The 5 Key Questions Addressed by this Report:...